Health Care & Life Sciences » Pharmaceuticals | AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
208,397.00
57,636.40
355,000.00
438,000.00
Depreciation, Depletion & Amortization
101,248.70
152,814.80
174,263.60
158,300.00
147,400.00
Other Funds
862,238.60
-
5,146.20
-
-
Funds from Operations
147,112.80
82,005.00
202,057.20
440,000.00
510,100.00
Changes in Working Capital
175,486.60
328,262.10
415,803.00
2,400.00
342,500.00
Net Operating Cash Flow
28,373.80
410,267.10
617,860.20
437,600.00
167,600.00
Capital Expenditures
216,337.00
238,052.40
90,449.20
56,500.00
62,800.00
Sale of Fixed Assets & Businesses
33,067.90
2,393.70
1,269.50
2,300.00
300.00
Purchase/Sale of Investments
-
-
-
100.00
110,800.00
Net Investing Cash Flow
183,269.10
235,658.70
89,179.70
54,100.00
173,300.00
Net Financing Cash Flow
862,238.60
-
5,146.20
-
-
Net Change in Cash
707,343.30
645,925.80
523,534.30
383,500.00
5,700.00
Free Cash Flow
187,963.20
648,319.50
527,411.00
381,100.00
104,800.00

About AstraZeneca Pharma India

View Profile
Address
Block N1, 12th Floor
Bangalore Karnataka 560045
India
Employees -
Website http://www.astrazeneca.com/country-sites/india.html
Updated 09/14/2018
AstraZeneca Pharma India Ltd. engages in the manufacture, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular/metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.